CD9 and glioma: Univariate and multivariate Cox regression analyses were performed to evaluate the impact of Radiotherapy, Chemotherapy, WHO grade, IDH status, MGMT methylation status, 1p19q codeletion status, age, gender, and CD9 expression on glioma prognosis.